TIS tissue therapies limited
Add to My Watchlist 0.00% ! 0.0¢

Ann: Regulatory Update , page-3

  1. Patrolly
    2,899 Posts.
    lightbulb Created with Sketch. 76
    clock Created with Sketch.
    18/03/13
    09:31
    Post #: 11550961
    here lies the problem

    The EMA approval process excludes sponsor companies like Tissue Therapies from direct
    contact with the EMA. The Company has been entirely dependent on BSI to make the
    submissions and to keep it informed.

    the process is flawed
    TIS Price at posting: 24.3¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 5  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS MTM Successful Uplisting Commences Trading on OTCQX Market in US
right-arrow Created with Sketch.
NEWS Austral Resources to Acquire Rocklands to Transform North-West Queensland Copper
right-arrow Created with Sketch.
NEWS Paris Gold Project Drilling Underway Testing High-Grade Zones
right-arrow Created with Sketch.
NEWS Listen: HotCopper Wire Podcast 016 – FY25 ended up not so bad... but Trump unpause is coming
right-arrow Created with Sketch.
NEWS R&D Tax Refund of $5.8M Received by Imugene to Support Clinical Development
right-arrow Created with Sketch.
NEWS Drilling Commences at Leinster South Project in WA
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.